Fusion event
HBV-chr9 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CAATCTCGGGAATCTCAATGTTAGTATTCCTTGGACTCATAAGGTGGGGAACTTTACTGGGCTTTATTCTTCTACTGTACCTGTCTTTAATCCTCATTGG| |AAAACACCATCTTTTCCTAATATACATTTACACCAAGACATTATCAAAAAATGTGAACAGTTTGTAGGCCCACTCACAGTTAATGAGAAAAGAAGATTGC
End
90879986/88265071 (Hg38)
Nearest miRNA
hsa-mir-101-2/Upstream/4295214; hsa-let-7a-1/Downstream/480765;
Upstream sequence
gaacagtagggggtgaaccgcccacatgattcagttatctcccactggatccctcccacaacacatgggaattatgggagctgcaattcaagatgagatt
Downstream sequence
CTGGGATCTGCAGCTGCACCCTGGCCTCTCAGGAGCCACCATGTAGCAGGGCTAACACTGCCCACAGCAGCGGCACCTCAAGATCAAGCCAAGAAATACT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.